Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IDEXX Laboratories, Inc. (IDXX : NSDQ)
 
 • Company Description   
IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $559.37 Daily Weekly Monthly
20 Day Moving Average: 649,583 shares
Shares Outstanding: 78.88 (millions)
Market Capitalization: $44,124.79 (millions)
Beta: 1.58
52 Week High: $769.98
52 Week Low: $496.61
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.28% -5.15%
12 Week -15.34% -21.73%
Year To Date -17.32% -24.84%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
ONE IDEXX DRIVE
-
WESTBROOK,ME 04092
USA		 ph: 207-556-0300
fax: 207-556-4346		 investorrelations@idexx.com http://www.idexx.com
 
 • General Corporate Information   
Officers
Jonathan J. Mazelsky - President; Chief Executive Officer and Director
Lawrence D. Kingsley - Chairman
Andrew J. Emerson - Executive Vice President; Chief Financial Officer
Irene Chang Britt - Director
Bruce L. Claflin - Director

Peer Information
IDEXX Laboratories, Inc. (ABMD)
IDEXX Laboratories, Inc. (DMDS)
IDEXX Laboratories, Inc. (CPWY.)
IDEXX Laboratories, Inc. (EQUR)
IDEXX Laboratories, Inc. (ECIA)
IDEXX Laboratories, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45168D104
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/03/26
Share - Related Items
Shares Outstanding: 78.88
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.58
Market Capitalization: $44,124.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.94 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $14.68 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 11.73% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 38.10
Trailing 12 Months: 41.19
PEG Ratio: 3.25
Price Ratios
Price/Book: 28.36
Price/Cash Flow: 37.08
Price / Sales: 9.92
EPS Growth
vs. Year Ago Period: 17.23%
vs. Previous Quarter: 12.66%
Sales Growth
vs. Year Ago Period: 14.26%
vs. Previous Quarter: 4.61%
ROE
03/31/26 - 70.87
12/31/25 - 69.78
09/30/25 - 67.78
ROA
03/31/26 - 32.56
12/31/25 - 31.91
09/30/25 - 31.08
Current Ratio
03/31/26 - 1.12
12/31/25 - 1.23
09/30/25 - 1.18
Quick Ratio
03/31/26 - 0.82
12/31/25 - 0.90
09/30/25 - 0.87
Operating Margin
03/31/26 - 24.63
12/31/25 - 24.62
09/30/25 - 24.65
Net Margin
03/31/26 - 24.63
12/31/25 - 24.62
09/30/25 - 24.65
Pre-Tax Margin
03/31/26 - 30.80
12/31/25 - 30.77
09/30/25 - 30.56
Book Value
03/31/26 - 19.73
12/31/25 - 20.10
09/30/25 - 19.55
Inventory Turnover
03/31/26 - 4.37
12/31/25 - 4.22
09/30/25 - 4.09
Debt-to-Equity
03/31/26 - 0.19
12/31/25 - 0.23
09/30/25 - 0.24
Debt-to-Capital
03/31/26 - 16.16
12/31/25 - 18.93
09/30/25 - 19.36
 

Powered by Zacks Investment Research ©